ENPH vs FATE · P/E 56, rev $1.47B vs rev $3.4M
Enphase Energy Inc (ENPH) versus Fate Therapeutics Inc (FATE) — a side-by-side from cached financials, not a winner call.
Enphase Energy Inc (ENPH) is a solar company listed on US. It is led by Badrinarayanan Kothandaraman.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
Latest reported ENPH revenue for 2025-12-31 was $1.47B. Net income was $172.1M. Revenue was up 10.7% from 2024-12-31 to 2025-12-31. ENPH currently screens at market cap $7.39B and trailing P/E 55.5.
Latest reported FATE revenue for 2026-06-30 was $3.4M. Net income was -$61.4M. FATE currently screens at market cap $331.0M.
ENPH currently screens at market cap $7.39B and trailing P/E 55.5. FATE currently screens at market cap $331.0M.
Not investment advice. Open the ENPH and FATE stock pages for the full models.
Not investment advice.